Kramer W, Burger H J, Arion W J, Corsiero D, Girbig F, Weyland C, Hemmerle H, Petry S, Habermann P, Herling A
Hoechst Marion Roussel Deutschland GmbH, DG Metabolic Diseases, D-65926 Frankfurt am Main, Germany. Werner.Kramerhmrag.com
Biochem J. 1999 May 1;339 ( Pt 3)(Pt 3):629-38.
The glucose-6-phosphatase system catalyses the terminal step of hepatic glucose production from both gluconeogenesis and glycogenolysis and is thus a key regulatory factor of blood glucose homoeostasis. To identify the glucose 6-phosphate transporter T1, we have performed photoaffinity labelling of human and rat liver microsomes by using the specific photoreactive glucose-6-phosphate translocase inhibitors S 0957 and S 1743. Membrane proteins of molecular mass 70, 55, 33 and 31 kDa were labelled in human microsomes by [3H]S 0957, whereas in rat liver microsomes bands at 95, 70, 57, 54, 50, 41, 33 and 31 kDa were detectable. The photoprobe [3H]S 1743 led to the predominant labelling of a 57 kDa and a 50 kDa protein in the rat. Stripping of microsomes with 0.3% CHAPS retains the specific binding of T1 inhibitors; photoaffinity labelling of such CHAPS-treated microsomes resulted in the labelling of membrane proteins of molecular mass 55, 33 and 31 kDa in human liver and 50, 33 and 31 kDa in rat liver. Photoaffinity labelling of human liver tissue samples from a healthy individual and from liver samples of patients with a diagnosed glycogen-storage disease type 1b (GSD type 1b; von Gierke's disease) revealed the absence of the 55 kDa protein from one of the patients with GSD type 1. These findings support the identity of the glucose 6-phosphate transporter T1, with endoplasmic reticulum protein of molecular mass 50 kDa in rat liver and 55 kDa in human liver.
葡萄糖-6-磷酸酶系统催化糖异生和糖原分解过程中肝脏葡萄糖生成的终末步骤,因此是血糖稳态的关键调节因子。为了鉴定葡萄糖-6-磷酸转运体T1,我们使用特异性光反应性葡萄糖-6-磷酸转运酶抑制剂S 0957和S 1743对人和大鼠肝脏微粒体进行了光亲和标记。[3H]S 0957标记了人微粒体中分子量为70、55、33和31 kDa的膜蛋白,而在大鼠肝脏微粒体中可检测到95、70、57、54、50、41、33和31 kDa的条带。光探针[3H]S 1743导致大鼠中57 kDa和50 kDa蛋白的主要标记。用0.3% CHAPS剥离微粒体可保留T1抑制剂的特异性结合;对这种经CHAPS处理的微粒体进行光亲和标记,导致人肝脏中分子量为55、33和31 kDa的膜蛋白以及大鼠肝脏中50、33和31 kDa的膜蛋白被标记。对一名健康个体的人肝脏组织样本以及一名被诊断为1b型糖原贮积病(GSD 1b型;冯·吉尔克病)患者的肝脏样本进行光亲和标记,发现其中一名GSD 1型患者缺乏55 kDa蛋白。这些发现支持了葡萄糖-6-磷酸转运体T1与大鼠肝脏中分子量为50 kDa、人肝脏中分子量为55 kDa的内质网蛋白具有同一性。